TY  - JOUR
AU  - Obón-Santacana, Mireia
AU  - Lujan-Barroso, Leila
AU  - Travis, Ruth C
AU  - Freisling, Heinz
AU  - Ferrari, Pietro
AU  - Severi, Gianluca
AU  - Baglietto, Laura
AU  - Boutron-Ruault, Marie-Christine
AU  - Fortner, Renée T
AU  - Ose, Jennifer
AU  - Boeing, Heiner
AU  - Menéndez, Virginia
AU  - Sánchez-Cantalejo, Emilio
AU  - Chamosa, Saioa
AU  - Castaño, José María Huerta
AU  - Ardanaz, Eva
AU  - Khaw, Kay-Tee
AU  - Wareham, Nick
AU  - Merritt, Melissa A
AU  - Gunter, Marc J
AU  - Trichopoulou, Antonia
AU  - Papatesta, Eleni-Maria
AU  - Klinaki, Eleni
AU  - Saieva, Calogero
AU  - Tagliabue, Giovanna
AU  - Tumino, Rosario
AU  - Sacerdote, Carlotta
AU  - Mattiello, Amalia
AU  - Bueno-de-Mesquita, H B
AU  - Peeters, Petra H
AU  - Onland-Moret, N Charlotte
AU  - Idahl, Annika
AU  - Lundin, Eva
AU  - Weiderpass, Elisabete
AU  - Vesper, Hubert W
AU  - Riboli, Elio
AU  - Duell, Eric J
PY  - 2015
DO  - 10.1158/1055-9965.EPI-15-0822
UR  - http://hdl.handle.net/10668/9630
T2  - Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
AB  - Acrylamide was classified as "probably carcinogenic to humans (group 2A)" by the International Agency for Research on Cancer. Epithelial ovarian cancer (EOC) is the fourth cause of cancer mortality in women. Five epidemiological studies have evaluated...
LA  - en
KW  - Acrylamide
KW  - Adenocarcinoma, Clear Cell
KW  - Adenocarcinoma, Mucinous
KW  - Biomarkers
KW  - Case-Control Studies
KW  - Cystadenocarcinoma, Serous
KW  - Endometrial Neoplasms
KW  - Epoxy Compounds
KW  - Female
KW  - Follow-Up Studies
KW  - Hemoglobins
KW  - Humans
KW  - Middle Aged
KW  - Neoplasm Invasiveness
KW  - Neoplasm Staging
KW  - Nutrition Assessment
KW  - Ovarian Neoplasms
KW  - Postmenopause
KW  - Prognosis
KW  - Prospective Studies
KW  - Risk Factors
TI  - Acrylamide and Glycidamide Hemoglobin Adducts and Epithelial Ovarian Cancer: A Nested Case-Control Study in Nonsmoking Postmenopausal Women from the EPIC Cohort.
TY  - research article
VL  - 25
ER  -